Composite endpoints for malaria case-management: not simplifying the picture? by Cairns, Matthew E et al.
Cairns, ME; Leurent, B; Milligan, PJ (2014) Composite endpoints
for malaria case-management: not simplifying the picture? Malar J,
13. p. 494. ISSN 1475-2875 DOI: 10.1186/1475-2875-13-494
Downloaded from: http://researchonline.lshtm.ac.uk/2078045/
DOI: 10.1186/1475-2875-13-494
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
COMMENTARY Open Access
Composite endpoints for malaria case-
management: not simplifying the picture?
Matthew E Cairns*, Baptiste Leurent and Paul J Milligan
Abstract
Rapid diagnostic tests (RDTs) for infection with Plasmodium spp. offer two main potential advantages related to
malaria treatment: 1) ensuring that individuals with malaria are promptly treated with an effective artemisinin-based
combination therapy, and 2) ensuring that individuals without malaria do not receive an anti-malarial they do not
need (and instead receive a more appropriate treatment). Some studies of the impact of RDTs on malaria case
management have combined these two different successes into a binary outcome describing ‘correct management’.
However combining correct management of positives and negatives into a single summary measure can be misleading.
The problems, which are analogous to those encountered in the evaluation of diagnostic tests, can largely be avoided if
data for patients with and without malaria are presented and analysed separately. Where a combined metric is necessary,
then one of the established approaches to summarise the performance of diagnostic tests could be considered, although
these are not without their limitations. Two graphical approaches to help understand case management performance
are illustrated.
Background
Case management of malaria has been revolutionised by
the introduction of rapid diagnostic tests (RDTs), which
allow parasitological diagnosis at the point of care in a
much wider range of settings than was previously pos-
sible [1]. Diagnostic testing is the first stage of the ‘T3:
Test. Treat. Track.’ approach recommended by WHO
[2]. The potential advantages of wider availability and
higher quality of diagnostics are two-fold: firstly, increas-
ing the percentage of those with malaria who receive
prompt and effective treatment with an artemisinin-based
combination therapy (ACT), and secondly, increasing the
percentage of those without malaria who do not receive
an antimalarial and instead are managed appropriately
according to their condition [3]. Withholding treatment
from RDT-negative patients should avoid unnecessary side
effects, avoid wasted drugs, and help reduce selection
pressure for resistance to antimalarials used for case man-
agement [3], although some of these benefits have been
challenged in certain situations [4]. A further benefit of
identifying malaria-negative cases is that this may help
determine the true cause of fever, which could lead to
better clinical outcomes. However, a recent study in
Tanzania showed that 70% of patients presenting with
fever had a viral illness as the underlying cause [5]; there
may be limited scope for improved clinical outcomes
where there is no obvious treatment beyond management
of symptoms. Over-use of antibiotics among those who
test negative for malaria is also a concern [6]. Guidelines
for the evaluation of diagnostic procedures emphasise
the importance of measuring clinical benefit [7,8] but in
practice evaluation has often relied on assessment of
sensitivity, specificity and predictive values [7].
To address these issues, a number of studies have
looked at the impact of RDTs on adherence to the
current guidelines for malaria treatment [3]. In some of
these studies the two different successes (treatment of
positives and non-treatment of negatives) have been
combined into a composite outcome describing the
overall success rate of ‘correctly managed’ patients,
either for descriptive purposes or to create a binary out-
come that is used for formal analyses. This appears to
have been done for two main reasons. Firstly, to provide
a simple, summary measure of case-management suc-
cess, which might seem appealing when comparing
different diagnostic strategies, or in a randomised trial
where defining a unique primary outcome is usually rec-
ommended. For example, a composite outcome has been
* Correspondence: matthew.cairns@lshtm.ac.uk
MRC Tropical Epidemiology Group, London School of Hygiene and Tropical
Medicine, Keppel Street, London WC1E 7HT, UK
© 2014 Cairns et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Cairns et al. Malaria Journal 2014, 13:494
http://www.malariajournal.com/content/13/1/494
used to describe the situation in cross-sectional studies
prior to RDTs being introduced [9] or following introduc-
tion of RDTs [10], to compare case management following
an intervention to improve management of febrile patients
[11] and to monitor changes in case-management over
time [12]. Secondly, in many settings the proportion of pa-
tients with malaria is low, and therefore when looking at
factors associated with correct management of parasitae-
mic patients, there are an insufficient number of positives
to allow a meaningful analysis of risk factors. Combining
the positives with the larger number of negatives appears
to have been undertaken to provide a larger sample size
for multivariable analysis [9-11]. However, as shown
below, combining correct management of positives and
negatives at best provides an ‘average’ that is hard to
compare with other settings, and at worst distorts the
true situation. Separate presentation and analysis of
positives and negatives would avoid these issues.
Problems with a composite outcome of case-management
success
A number of the issues related to combining all cor-
rectly managed patients together are analogous with
well-established theory related to diagnostic tests: sensi-
tivity and specificity are routinely reported as inherent
characteristics of a test, rather than the overall percent
correctly diagnosed, because for a particular test, the
percent correctly diagnosed will depend on the relative
number of positives and negatives that take the test.
Likewise, the overall percent of patients that are cor-
rectly managed in a particular scenario (the combined
management rate, CMR) depends on 1) the percentage
of true positives who are successfully managed (positive
management rate, PMR, analogous to sensitivity), 2) the
percentage of true negatives who are successfully man-
aged (negative management rate, NMR, analogous to
specificity), and 3) the relative frequency of positives and
negatives who must be managed (the prevalence among
those seeking treatment) (Table 1). Note that these are
not true rates but proportions. However, unless the PMR
and NMR are identical, then the CMR will vary as a
function of prevalence, being equal to the NMR at zero
prevalence and equal to the PMR in the (hypothetical)
situation of 100% prevalence. Comparisons of the CMR
between scenarios (over time for a particular location, or
between locations) are only straightforward to interpret
if prevalence is the same, and if one of the two manage-
ment rates remains constant. In scenarios with low
prevalence (which will be found far more commonly
than prevalence close to 100%), the management of
parasite negative individuals will dominate the overall
combined management rate, and could mask genuine
improvements (or deterioration) in the appropriate man-
agement of parasitaemic patients.
Furthermore, combining management of malaria posi-
tives and malaria negatives together implicitly gives
equal weight to each of these (and equal weight to the
corresponding failure to manage correctly). The relative
importance of correctly managing both types of patient
is likely to differ depending on the application (e.g. treating
acutely ill patients versus mass-screening and treatment of
asymptomatics to reduce transmission), but arguably, fail-
ure to treat a patient with malaria is usually more serious
than inadvertently providing an ACT to a malaria negative
patient. Methods from the diagnostic literature exist that
would allow this weighting to be altered, in the same way
that sensitivity or specificity could be considered as more
important for a diagnostic test [13], or performance of a
test weighted by utility gains and losses [14]. However, the
choice of weights is subjective. Description and analysis of
positives and negatives separately avoids having to make
this judgement, leaving this to the interpretation stage,
and allows comparison between settings without having to
formalise the weighting.
Finally, regression of combined correct management
as a binary outcome could mask factors that are associ-
ated with correct treatment of positives, particularly if
prevalence among those seeking care is low. For ex-
ample, a hypothetical risk factor that is strongly associ-
ated with correct management of positives (an odds
ratio of approximately 3) if observed among 100 posi-
tives, would not be identified as being associated when
combined with 900 negatives, if there is no association
of the risk factor with correct management of negatives
(Table 2). It will also be misleading if the factor is differ-
entially associated with the PMR and NMR, as might be
the case for factors such as ACT availability (low stock
might lead to highly selective use (low PMR, high
NMR), and vice versa). Whether the association between
factors and correct management differs according to the
malaria status can formally be investigated using tests
Table 1 Measures of case management success
True status
How managed Positive Negative Total
Treated a c a+c
Not treated b d b+d
Total a+b c+d N
Prevalence (a+b)/N
Positive management rate (PMR) a/(a+b)
Negative management rate (NMR) d/(c+d)
Combined management rate (CMR) (a+d)/N OR
PMR*p+NMR*(1-p)
Predictive values
% positive among treated a/(a+c)
% negative among not treated d/(b+d)
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for interaction (effect modification). However, these tests
are not always performed, and typically have low power.
In addition, if the PMR and NMR differ, then because
the CMR will change with malaria prevalence as described
above, any factors that are themselves associated with
prevalence (e.g. age), will appear associated with the CMR.
Composite outcomes from the diagnostic literature
The literature on evaluation of diagnostic tests recom-
mends against using the overall accuracy to compare tests
(e.g. [13,15]). For meta-analyses, bivariate approaches can
account for sensitivity and specificity simultaneously [16].
If a single measure is desired for summary purposes, a
number of options exist (Table 3) but each has its limita-
tions. In the definitions that follow, to illustrate the
example of case management considered here, positive
management rate has been substituted for sensitivity, and
the negative management rate for specificity.
Youden’s index [17] combines PMR and NMR as (Y =
PMR + NMR - 1), which is not affected by prevalence,
but has the problem that different combinations of PMR
and NMR can give the same value of the index (i.e. the
index is degenerate, and thus when presented alone is
not very informative). The diagnostic odds ratio (DOR)
has also been suggested as a summary measure, this is
calculated as [PMR/(1-PMR)] / [(1-NMR)/NMR] i.e. the
odds of receiving an ACT among those with malaria,
relative to the odds of receiving an ACT among those
without malaria. Alternatively, the DOR can be inter-
preted as the odds of malaria among those treated, rela-
tive to the odds among those not treated. The DOR
does not depend on the prevalence but a drawback is
that this index is also degenerate [15]. Further, if the
2 × 2 table contains zeroes (for example if all positives
are managed appropriately), the DOR will be undefined.
Alternatively, the ratio of the true-positive rate to the
false-positive rate (likelihood ratio for positives, LR+ =
PMR/[1–NMR]) and the false negative rate to the true
negative rate (likelihood ratio for negatives LR− = [1-
PMR]/NMR) can be calculated. Higher values of LR+
indicate better discrimination, as a higher proportion of
those treated were actually infected. Conversely, smaller
values of LR− indicate better discrimination, because
they show that fewer of those not treated were not in-
fected. LR+ and LR− do not depend on the prevalence of
the disease. Note that the DOR is the ratio LR+/LR-.
Biggerstaff [18] describes a graphical approach to com-
pare diagnostic tests using the likelihood ratios, which
could be used to compare different case-management
strategies. An example using data from a recent trial to
improve adherence to malaria treatment guidelines [19]
is shown in Figure 1. In the control group, 208/278 pa-
tients with malaria received an ACT (PMR = 74.8%); but
only 38/239 negative patients did not receive an ACT
(NMR = 15.9%). In the group given enhanced training,
363/498 patients with malaria received an ACT (PMR =
72.9%), and 527/759 negatives were not treated (NMR =
69.4%). Thus the main change was an improvement in
the management of negatives, at the cost of a slight fall
in the correct management of positives. When a new
strategy falls in the upper left quadrant or lower right
quadrant (as defined by the lines of equivalent PMR and
NMR to the reference strategy), the new strategy is
clearly superior or clearly inferior, respectively. When a
new strategy falls into the bottom left or upper right
quadrant, whether this is preferred will depend on how
much of a decrease in NMR or PMR can be compen-
sated by an increase in the other rate. According to the
method proposed by Biggerstaff, any combination of
PMR and NMR that lies above the lines for the LR+ and
LR− (the area shaded blue in Figure 1) would be consid-
ered ‘superior’ on the basis of the likelihood ratios. How-
ever, a case management strategy with a higher LR+ and
lower LR− will not systematically be preferred, because
Table 2 Hypothetical result showing masking of risk factor in combined analysis
True status
Malaria (N = 100) No malaria (N = 900)
Exposed Unexposed Exposed Unexposed
Correct management 37 25 225 225
Incorrect management 13 25 225 225
Total 50 50 450 450
Stratified odds ratio 2.85 (1.23, 6.60), p = 0.015 1.00 (0.77, 1.30) p = 1.0
Combined OR 1.10 (0.86, 1.41), p = 0.45
Table 3 Combined measures of overall case management
success
Measures of overall success Formula
Youdens index PMR+NMR - 1
Likelihood ratio for positives (LR+) PMR/[1 – NMR]
Likelihood ratio for negatives (LR−) [1 – PMR]/NMR
Diagnostic Odds ratio [ PMR/(1-PMR)]/[(1-NMR)/NMR]
PMR: positive management rate; NMR: negative management rate.
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different importance may be attached to failure to treat
positives, or the incorrect treatment of negatives.
Newcombe [13] describes a graphical approach that
allows the relative importance of the two types of incor-
rect diagnosis to be specified in a simultaneous compari-
son of sensitivity and specificity between two tests, (or
as applied to the current example, simultaneous com-
parison of case management of positives and negatives
between two different management strategies). This is
done by plotting the difference in the probability of cor-
rect management between the two strategies as a function
of the prevalence, with a confidence interval. The case
management strategy being evaluated can be considered
superior to the control where this interval lies entirely
above zero. Different relative importance can be assigned
to the two possible case-management errors (failing to
treat a patient with malaria and treating a patient without
malaria unnecessarily). Although this additional weighting
is subjective, it is at least explicit, and can easily be chan-
ged to simulate different scenarios.
The weighted difference in probability of correct man-
agement between the two strategies, denoted f, is calcu-
lated as described in [13] and summarised in Table 4. A
plot of the weight, denoted by lambda (λ), against preva-
lence for five different scenarios is shown in Figure 2A):
equal importance given to both types of error (relative
Figure 1 Biggerstaff method for comparing case-management strategies. The blue diamond shows the positive management rate plotted
against 1- negative management rate for the control group in [19]. The red square shows the estimate of PMR and 1- NMR for the enhanced
training group. Dotted red lines show equivalent PMR and NMR. The upper left rectangle (upward shading) shows the region where a strategy
would be considered superior both in term of NMR and PMR; the lower right quadrant (downward shading) shows the region where a new strategy
would be considered inferior in terms of NMR and PMR. The solid black line shows the line of constant likelihood ratio for positives, and the dashed
black line shows the line of constant likelihood ratio for negatives. The blue shaded area shows the region where an alternative strategy would
be considered superior on the basis of higher LR+ and lower LR-, as discussed in Biggerstaff [18].
Table 4 Mathematical details of the Newcombe method
1. For each value of prevalence (p) from 0 to 1, the difference in probability of correct management between the strategies, denoted f , is obtained
by calculating a (weighted) mean of the difference in the PMR between the two strategies (θ1) and the difference in the NMRs (θ2):
f = λθ1 + (1 − λ)θ2
where the weight, λ is calculated as λ ¼ 1
1þc2 1−pð Þc1p
and
c1 = subjective weight indicating ‘importance’ of treating a malaria patient (avoiding false negatives)
c2 = subjective weight indicating ‘importance’ of avoiding treating a patient without malaria (false positives)
2. For clarity of presentation the relative importance of false negatives to false positives is defined as
R = c1/c2
If c1 = c2 (R = 1) the equation for λ simplies to λ ¼ 1
1þ 1−pð Þp
i.e. λ = p
3. A confidence interval for f can be calculated as described in Newcombe [13] and http://medicine.cf.ac.uk/primary-care-public-health/resources/.
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importance of false negatives to false positives, R = 1),
false negatives considered twice as important as false
positives (R = 2), false negatives ten times as important
as false positives (R = 10), false positives twice as import-
ant as false negatives (R = 0.5), false positives ten times
as important as false negatives (R = 0.1). This shows that
if the PMR is prioritised (R > 1), i.e. false negatives
(missed malaria cases) are emphasised, lambda rises
more steeply at low prevalence, and thus the PMR has
more influence on the weighted difference. Conversely,
if the false positives are prioritised (R < 1), then the
NMR has more influence.
The implications of this for the weighted difference in
probability of correct management between the two
strategies are shown in Figures 2B-F, using data from the
study by Mbacham et al. [19] as an example. Where the
confidence interval for the weighted mean crosses 0, this
indicates that the experimental group is no longer sig-
nificantly better than the control group. Assuming equal
weight of missed malaria patients and unnecessary treat-
ments, there is an advantage of the enhanced training
group in all situations apart from very high prevalence
(Figure 2B), due to the increased specificity. If false neg-
atives are considered twice as important (Figure 2C), this
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Figure 2 Illustration of the Newcombe method. Method from Newcombe [13], using the spreadsheet available from http://medicine.cf.ac.uk/
primary-care-public-health/resources/. In [13], the difference in probability of correct diagnosis is plotted against lambda. Here the relationship of
lambda to prevalence is shown in figure A), and the difference in probability of correct management is shown against prevalence in figures B)-F) for
different values of R; blue lines show 95% confidence interval. R is the ratio of importance of false negatives (c1) to the importance of false positives
(c2), i.e. R = c1/c2 (Table 4). At prevalence = 0 the difference is equal to the difference in the NMR between the enhanced and control groups, and at
prevalence = 1 the difference is equal to the difference in PMR between the two strategies.
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reduces the upper prevalence limit where the enhanced
group would be considered significantly superior to around
70%. If missed malaria cases are considered to be ten times
more important than treated negatives (Figure 2D), this
prevalence limit is around 20%, because the slightly lower
PMR in the enhanced training group is more heavily pena-
lised. Figure 2E and 2F show that if specificity is considered
more important (which is unlikely to be the case for mal-
aria, but shown for completeness), the better NMR offered
in the enhanced group means it is superior at all but the
very highest levels of prevalence. This approach therefore
provides a simple visual way to summarise the two aspects
of case management performance, and extend results from
one setting to areas with different prevalence. A limitation
of this simple graphical approach is that adjustment is not
made for covariates, but regression-based approaches to
do this are available [20]. Extending results between set-
tings is also complicated by the fact that the prior belief of
clinicians and health workers that a patient has malaria will
vary between settings with different current (or historic)
malaria prevalence. This may influence the success of a
specific intervention package intended to improve case
management on the basis of RDTs.
Conclusions
For the reasons outlined above, analysis of case manage-
ment stratified on positives and negatives will usually be
more informative than an analysis that combines cor-
rectly managed positives and negatives into a single ‘suc-
cess’. Stratified results are more comparable between
settings, and are therefore more useful to others working
in areas where prevalence is different, or where preva-
lence is changing. An implicit requirement for assessing
case management according to parasitaemia status is
that a test result is available for each person managed;
this requires that a test is available and that the health
worker chooses to use it. In practice, this will not always
be the case. Understanding what proportion of individ-
uals that should be tested are not tested, and why, could
be done separately, with the approaches discussed above
then used for those with a test result.
Having tested for malaria, one result gives a straight-
forward course of action: parasitaemic individuals with
fever or other symptoms of malaria should receive an
ACT. For the individuals seeking treatment who do not
have malaria, defining an appropriate course of action is
more complex. One point is that they do not need to
receive ACT, but assessing appropriate treatment will
require additional clinical judgement and potentially use
of further diagnostics, since having established that mal-
aria is not the cause of illness is only a first step in en-
suring that the true causes are identified and the patient
appropriately managed [7]. Reporting a single metric
combines these two distinct issues and is therefore
unlikely to be helpful in terms of advancing management
of either malaria or febrile illness of other aetiologies.
Separate presentation and analysis of patients with mal-
aria and patients without malaria should therefore be
encouraged. Where a summary measure is needed, ap-
proaches from the diagnostic literature are likely to be
more appropriate than a simple combined outcome, al-
though caution is needed in interpretation, and, ideally,
overall clinical outcomes should be evaluated.
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